[Study of quantitative detection of circulating DNA in the plasma of patients with cervical lesion]

Zhonghua Fu Chan Ke Za Zhi. 2011 Jul;46(7):501-4.
[Article in Chinese]


Objective: To quantitatively detect circulating DNA levels in the plasma of patients withcervical lesion and to determine the value for diagnosis of cervical lesion and cervical cancer.

Methods: Preoperative blood samples were collected from 53 cases of low-grade lesions, 49 cases of high-grade lesions, 44 cases of cervical invasive cancer and 70 cases of healthy women. Plasma DNA was extracted by magnetic bead method (BILATEST DNA kit). The quantity of plasma DNA was determined by duplex real-time quantitative PCR.

Results: Median plasma DNA level of invasive cervical cancer patients was 61.59 mg/L (32.06-162.16 mg/L), which was significantly higher than that of healthy women [16.35 mg/L (11.98-22.71 mg/L), P<0.01]. Among invasive cervical cancer patients, median plasma DNA level of squamous carcinoma patients was slightly higher than that of adenocarcinoma (50.43 versus 47.31 mg/L, P>0.05). Median plasma DNA level of stage I patients was lower than that of stage II-III patients (46.02 versus 71.35 mg/L, P<0.05).

Conclusion: Quantitatively detecting plasma circulating DNA may be with some application prospect in the diagnosis of cervical diseases.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / blood
  • Adenocarcinoma / diagnosis
  • Adult
  • Biomarkers, Tumor / blood*
  • Biomarkers, Tumor / isolation & purification
  • Carcinoma, Squamous Cell / blood*
  • Carcinoma, Squamous Cell / diagnosis
  • Case-Control Studies
  • DNA / blood*
  • DNA / isolation & purification
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Staging
  • Real-Time Polymerase Chain Reaction
  • Sensitivity and Specificity
  • Uterine Cervical Dysplasia / blood*
  • Uterine Cervical Dysplasia / diagnosis
  • Uterine Cervical Neoplasms / blood*
  • Uterine Cervical Neoplasms / diagnosis


  • Biomarkers, Tumor
  • DNA